Stockreport

Why Is Immuneering Stock Trading Higher On Tuesday? [Yahoo! Finance]

Immuneering Corporation - Class A  (IMRX) 
PDF On Tuesday, Immuneering Corporation (NASDAQ: IMRX ) revealed data updates from three pancreatic cancer arms of its ongoing Phase 2a trial of lead program IMM-1-104 and [Read more]